These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21575932)

  • 1. Glutamatergic neurotransmission in a mouse model of Niemann-Pick type C disease.
    D'Arcangelo G; Grossi D; De Chiara G; de Stefano MC; Cortese G; Citro G; Rufini S; Tancredi V; Merlo D; Frank C
    Brain Res; 2011 Jun; 1396():11-9. PubMed ID: 21575932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased purinergic inhibition of synaptic activity in a mouse model of Niemann-Pick disease type C.
    Zhou SY; Xu SJ; Yan YG; Yu HM; Ling SC; Luo JH
    Hippocampus; 2011 Feb; 21(2):212-9. PubMed ID: 20082288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of ionotropic glutamate receptor-mediated processes in the rat hippocampus following repeated, brief seizures.
    Borbély S; Dobó E; Czégé D; Molnár E; Bakos M; Szucs B; Vincze A; Világi I; Mihály A
    Neuroscience; 2009 Mar; 159(1):358-68. PubMed ID: 19154779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: implications for seizure susceptibility.
    Balosso S; Ravizza T; Pierucci M; Calcagno E; Invernizzi R; Di Giovanni G; Esposito E; Vezzani A
    Neuroscience; 2009 Jun; 161(1):293-300. PubMed ID: 19285115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defects of synaptic vesicle turnover at excitatory and inhibitory synapses in Niemann-Pick C1-deficient neurons.
    Xu S; Zhou S; Xia D; Xia J; Chen G; Duan S; Luo J
    Neuroscience; 2010 May; 167(3):608-20. PubMed ID: 20167265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar-Kyoto rat).
    Howells FM; Russell VA
    Brain Res; 2008 Mar; 1200():107-15. PubMed ID: 18295191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological cholesterol metabolism fails to modify electrophysiological properties of afflicted neurones in Niemann-Pick disease type C.
    Deisz RA; Meske V; Treiber-Held S; Albert F; Ohm TG
    Neuroscience; 2005; 130(4):867-73. PubMed ID: 15652985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors.
    Woldbye DP; Nanobashvili A; Sørensen AT; Husum H; Bolwig TG; Sørensen G; Ernfors P; Kokaia M
    Neurobiol Dis; 2005 Dec; 20(3):760-72. PubMed ID: 15979311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kainate receptors and signal integration by NG2 glial cells.
    Kukley M; Dietrich D
    Neuron Glia Biol; 2009 May; 5(1-2):13-20. PubMed ID: 20025816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic impairment in Niemann-Pick C1-deficient neurons: not dependent on presence of glial cells.
    Xu S; Chen X; Wei X; Liu G; Wang Q
    Neurosci Lett; 2011 May; 496(1):54-9. PubMed ID: 21507342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postsynaptic modulation of AMPA receptor-mediated synaptic responses and LTP by the type 3 ryanodine receptor.
    Shimuta M; Yoshikawa M; Fukaya M; Watanabe M; Takeshima H; Manabe T
    Mol Cell Neurosci; 2001 May; 17(5):921-30. PubMed ID: 11358488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presynaptic kainate receptor facilitation of glutamate release involves protein kinase A in the rat hippocampus.
    Rodríguez-Moreno A; Sihra TS
    J Physiol; 2004 Jun; 557(Pt 3):733-45. PubMed ID: 15107475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological alterations of the cornea in the mouse model of niemann-pick disease type c1.
    Hovakimyan M; Stachs O; Reichard M; Mascher H; Lukas J; Frech MJ; Guthoff R; Witt M; Rolfs A; Wree A
    Cornea; 2011 Jul; 30(7):796-803. PubMed ID: 21317782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated 4-aminopyridine induced seizures diminish the efficacy of glutamatergic transmission in the neocortex.
    Világi I; Dobó E; Borbély S; Czégé D; Molnár E; Mihály A
    Exp Neurol; 2009 Sep; 219(1):136-45. PubMed ID: 19445932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional effects of somatostatin receptor 1 activation on synaptic transmission in the mouse hippocampus.
    Cammalleri M; Martini D; Timperio AM; Bagnoli P
    J Neurochem; 2009 Dec; 111(6):1466-77. PubMed ID: 19811607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.
    Murray TK; Whalley K; Robinson CS; Ward MA; Hicks CA; Lodge D; Vandergriff JL; Baumbarger P; Siuda E; Gates M; Ogden AM; Skolnick P; Zimmerman DM; Nisenbaum ES; Bleakman D; O'Neill MJ
    J Pharmacol Exp Ther; 2003 Aug; 306(2):752-62. PubMed ID: 12730350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Hippocampal i-LTP and LOX-1 Overexpression Induced by Anoxia: A Potential Role in Neurodegeneration in NPC Mouse Model.
    Lo Castro A; Murdocca M; Pucci S; Zaratti A; Greggi C; Sangiuolo F; Tancredi V; Frank C; D'Arcangelo G
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28678158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presynaptic and postsynaptic actions of halothane at glutamatergic synapses in the mouse hippocampus.
    Kirson ED; Yaari Y; Perouansky M
    Br J Pharmacol; 1998 Aug; 124(8):1607-14. PubMed ID: 9756375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased estradiol release from astrocytes contributes to the neurodegeneration in a mouse model of Niemann-Pick disease type C.
    Chen G; Li HM; Chen YR; Gu XS; Duan S
    Glia; 2007 Nov; 55(15):1509-18. PubMed ID: 17705200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Miglustat Reverts the Impairment of Synaptic Plasticity in a Mouse Model of NPC Disease.
    D'Arcangelo G; Grossi D; Racaniello M; Cardinale A; Zaratti A; Rufini S; Cutarelli A; Tancredi V; Merlo D; Frank C
    Neural Plast; 2016; 2016():3830424. PubMed ID: 26885401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.